Wu, J., Zhao, M., Wei, H., Li, C., Hu, D., Zheng, L., & Wang, D. W. (2022). Neuraminidase inhibitor treatment is associated with decreased mortality in COVID-19 patients: A retrospective analysis. European heart journal. Cardiovascular pharmacotherapy, 8(4), 392-401. https://doi.org/10.1093/ehjcvp/pvac018
Chicago Style (17th ed.) CitationWu, Junfang, Mingming Zhao, Haoran Wei, Chenze Li, Dong Hu, Lemin Zheng, and Dao Wen Wang. "Neuraminidase Inhibitor Treatment Is Associated with Decreased Mortality in COVID-19 Patients: A Retrospective Analysis." European Heart Journal. Cardiovascular Pharmacotherapy 8, no. 4 (2022): 392-401. https://doi.org/10.1093/ehjcvp/pvac018.
MLA (9th ed.) CitationWu, Junfang, et al. "Neuraminidase Inhibitor Treatment Is Associated with Decreased Mortality in COVID-19 Patients: A Retrospective Analysis." European Heart Journal. Cardiovascular Pharmacotherapy, vol. 8, no. 4, 2022, pp. 392-401, https://doi.org/10.1093/ehjcvp/pvac018.